Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

The government has proposed new rules for the nation's transplant system that aim to increase use of certain donated organs ...

UnitedHealth Group, Inc. (NYSE:UNH) experienced a historic market rout on Tuesday, with its stock plunging 20% in a single ...

The federal government has begun using artificial intelligence to review whether certain treatments are necessary for ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

To satisfy Republicans opposed to last summer's cuts to health care, the Trump administration launched an ambitious 5-year ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

A tiny pay raise and new restrictions for Medicare Advantage plans show the administration won't go easy on the industry.